In order to carry out genome-wide screening of genetic modifiers for DMBA/TPA-induced skin tumors, we generated p53+/− or p53+/+ backcross mice between FVB/N and MSM/Ms mice. The gene discussed is TP53; the disease is skin neoplasm.